FDA NDC Directory · JSON-LD · Markdown

topotecan hydrochloride

NDC 16729-151 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerAccord Healthcare, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202351
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTOPOTECAN HYDROCHLORIDE (4 mg/4mL)
Marketing started20130723
Package count1

External sources

Source: openFDA. Public-domain (CC0).